Insider Transactions in Q4 2017 at Summit Financial Group, Inc. (SMMF)
Insider Transaction List (Q4 2017)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 28
2017
|
Patrick Frye Sr. VP & Chief of Credit Admin |
SELL
Bona fide gift
|
Direct |
500
-1.58%
|
-
|
|
Dec 27
2017
|
Robert S Tissue Senior VP & CFO |
SELL
Bona fide gift
|
Direct |
565
-0.77%
|
-
|
|
Dec 22
2017
|
Bradford E Ritchie President, Subsidiary Bank |
SELL
Bona fide gift
|
Direct |
400
-2.33%
|
-
|
|
Dec 22
2017
|
Patrick Frye Sr. VP & Chief of Credit Admin |
BUY
Bona fide gift
|
Indirect |
500
+50.0%
|
-
|
|
Dec 22
2017
|
Patrick Frye Sr. VP & Chief of Credit Admin |
SELL
Bona fide gift
|
Direct |
500
-1.55%
|
-
|
|
Dec 21
2017
|
Dewey F Bensenhaver Director |
SELL
Open market or private sale
|
Direct |
950
-1.85%
|
$24,700
$26.14 P/Share
|
|
Dec 19
2017
|
Dewey F Bensenhaver Director |
SELL
Open market or private sale
|
Direct |
950
-1.82%
|
$23,750
$25.89 P/Share
|
|
Dec 15
2017
|
H Charles Maddy Iii President & CEO |
SELL
Open market or private sale
|
Direct |
1,900
-2.38%
|
$51,300
$27.28 P/Share
|
|
Dec 15
2017
|
Patrick Frye Sr. VP & Chief of Credit Admin |
SELL
Open market or private sale
|
Direct |
3
-0.01%
|
$81
$27.3 P/Share
|
|
Dec 14
2017
|
Dewey F Bensenhaver Director |
SELL
Open market or private sale
|
Direct |
940
-1.77%
|
$24,440
$26.29 P/Share
|
|
Dec 13
2017
|
Julie R Markwood EVP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,213
-30.11%
|
$32,751
$27.0 P/Share
|
|
Dec 12
2017
|
Dewey F Bensenhaver Director |
SELL
Open market or private sale
|
Direct |
946
-1.75%
|
$24,596
$26.36 P/Share
|
|
Dec 06
2017
|
H Charles Maddy Iii President & CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,169
-7.18%
|
$166,563
$27.14 P/Share
|
|
Dec 06
2017
|
H Charles Maddy Iii President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,940
+13.96%
|
$167,280
$12.01 P/Share
|
|
Dec 06
2017
|
Robert S Tissue Senior VP & CFO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,177
-4.17%
|
$85,779
$27.14 P/Share
|
|
Dec 06
2017
|
Robert S Tissue Senior VP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,178
+8.61%
|
$86,136
$12.01 P/Share
|
|
Dec 06
2017
|
Julie R Markwood EVP & Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,559
-27.9%
|
$42,093
$27.14 P/Share
|
|
Dec 06
2017
|
Julie R Markwood EVP & Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,522
+38.66%
|
$42,264
$12.01 P/Share
|
|
Dec 04
2017
|
Patrick Frye Sr. VP & Chief of Credit Admin |
SELL
Open market or private sale
|
Direct |
3,680
-10.27%
|
$99,360
$27.5 P/Share
|
|
Dec 04
2017
|
Patrick Frye Sr. VP & Chief of Credit Admin |
BUY
Exercise of conversion of derivative security
|
Direct |
3,680
+3.42%
|
$62,560
$17.74 P/Share
|
|
Dec 04
2017
|
Scott C Jennings EVP & COO |
SELL
Open market or private sale
|
Direct |
2,234
-64.07%
|
$60,318
$27.0 P/Share
|
|
Dec 01
2017
|
Scott C Jennings EVP & COO |
SELL
Open market or private sale
|
Direct |
1,646
-32.07%
|
$44,442
$27.0 P/Share
|
|
Dec 01
2017
|
Scott C Jennings EVP & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,880
+27.12%
|
$65,960
$17.74 P/Share
|
|
Nov 29
2017
|
H Charles Maddy Iii President & CEO |
BUY
Open market or private sale
|
Direct |
3,473
+4.6%
|
$93,771
$27.25 P/Share
|
|
Nov 28
2017
|
H Charles Maddy Iii President & CEO |
BUY
Open market or private sale
|
Direct |
327
+0.43%
|
$8,829
$27.25 P/Share
|
|
Nov 27
2017
|
Dewey F Bensenhaver Director |
SELL
Open market or private sale
|
Direct |
2,246
-3.99%
|
$58,396
$26.85 P/Share
|
|
Nov 16
2017
|
Dewey F Bensenhaver Director |
SELL
Open market or private sale
|
Indirect |
763
-24.33%
|
$19,838
$26.16 P/Share
|
|
Nov 14
2017
|
Gary L Hinkle Director |
BUY
Open market or private purchase
|
Direct |
1,293
+0.35%
|
$32,325
$25.12 P/Share
|
|
Nov 13
2017
|
Gary L Hinkle Director |
BUY
Open market or private purchase
|
Direct |
1,708
+0.46%
|
$42,700
$25.1 P/Share
|
|
Nov 07
2017
|
Gary L Hinkle Director |
BUY
Open market or private purchase
|
Direct |
2,330
+0.63%
|
$60,580
$26.52 P/Share
|
|
Nov 03
2017
|
Gary L Hinkle Director |
BUY
Open market or private purchase
|
Direct |
540
+0.07%
|
$14,040
$26.98 P/Share
|
|
Nov 02
2017
|
Robert S Tissue Senior VP & CFO |
SELL
Open market or private sale
|
Direct |
3,880
-5.32%
|
$104,760
$27.5 P/Share
|
|
Nov 02
2017
|
Robert S Tissue Senior VP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,880
+1.77%
|
$65,960
$17.74 P/Share
|
|
Nov 02
2017
|
Gary L Hinkle Director |
BUY
Open market or private purchase
|
Direct |
2,130
+0.58%
|
$55,380
$26.94 P/Share
|
|
Nov 02
2017
|
Thomas J Hawse Iii Director |
SELL
Open market or private sale
|
Direct |
500
-0.27%
|
$13,500
$27.33 P/Share
|
|
Nov 01
2017
|
H Charles Maddy Iii President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,800
+2.47%
|
$49,400
$13.64 P/Share
|
|
Nov 01
2017
|
Thomas J Hawse Iii Director |
SELL
Open market or private sale
|
Direct |
1,500
-0.8%
|
$40,500
$27.42 P/Share
|
|
Oct 31
2017
|
Thomas J Hawse Iii Director |
SELL
Open market or private sale
|
Direct |
1,000
-1.05%
|
$27,000
$27.29 P/Share
|
|
Oct 31
2017
|
Oscar M Bean Director |
SELL
Open market or private sale
|
Direct |
4,000
-4.45%
|
$108,000
$27.01 P/Share
|
|
Oct 31
2017
|
Oscar M Bean Director |
SELL
Bona fide gift
|
Direct |
100
-0.11%
|
-
|